Foundation Health is a technology company.
Foundation Health has raised $26.0M across 2 funding rounds.
Foundation Health has raised $26.0M in total across 2 funding rounds.
Foundation Health is a healthcare technology company building an AI-powered platform that integrates digital pharmacy, telehealth, diagnostics, and care coordination to streamline operations for consumer health businesses, pharma manufacturers, and healthcare organizations.[1][2][3] Its flagship PAIGE AI suite automates prior authorizations, patient communications, and workflows while enabling white-labeled, end-to-end solutions like virtual pharmacies, nationwide clinician networks, and direct-to-patient delivery, serving clients who need scalable, compliant healthcare experiences.[1][3] With $26 million in total funding—including a $20M Series A in October 2025 led by Define Ventures—the company, founded in 2023 and based in San Mateo, California, targets efficiency gains in fragmented pharmacy and telehealth sectors, empowering brands to launch services quickly with built-in compliance and cost savings.[2][3]
Foundation Health was founded in 2023 by a team of experts who previously built the first Pharmacy API, revolutionized B2B pharmacy with Pharmacy-as-a-Service, and developed digital pharmacy, telehealth, and diagnostics for Fortune 500 companies, including operating nationwide pharmacies, clinics, and diagnostic centers in the US and Europe.[1][3] The co-founders include veterans from Truepill, a prior pharmacy tech startup, bringing deep operational experience to address inefficiencies in consumer healthcare delivery.[4] Early traction came from delivering affordable, tech-enabled pharmacy and telehealth at scale, culminating in a $6M seed round followed by the $20M Series A in 2025, which validated their comprehensive platform approach amid rising demand for AI-driven automation.[2][3]
Foundation Health stands out through its end-to-end, AI-powered infrastructure that unifies fragmented healthcare workflows, unlike single-point solutions:
Foundation Health rides the wave of AI automation in healthcare, capitalizing on post-pandemic demand for digital-first pharmacy and telehealth amid labor shortages, rising costs, and regulatory pushes for patient-centric care.[1][3][5] Timing aligns with pharma's shift to DTP models and consumer health brands seeking integrated tools to bypass traditional bottlenecks, fueled by market forces like telehealth adoption (accelerated by COVID) and AI's ability to handle 80%+ of routine tasks like auths.[3] By empowering organizations with scalable infrastructure, it influences the ecosystem by enabling non-healthcare natives (e.g., retailers, brands) to enter digital health, fostering competition and innovation in a $4T+ US healthcare market fragmented by silos.[2][3]
With $26M in funding and a 2025 Series A signaling strong investor confidence, Foundation Health is poised to expand its PAIGE platform, targeting more pharma DTP launches and enterprise pharmacy integrations amid AI health tech's projected 40% CAGR.[3][5] Trends like multimodal AI for care coordination, regulatory tailwinds for virtual care, and home-delivery normalization will accelerate growth, potentially positioning it as a backbone for consumer health stacks. As it scales from <25 employees, expect partnerships with Fortune 500s to amplify influence, redefining accessible healthcare delivery just as its origins promised.[1][2][3]
Foundation Health has raised $26.0M in total across 2 funding rounds.
Foundation Health's investors include Calm/Storm Ventures, Define Ventures, Y Combinator, Andreessen Horowitz, Bora&Sons, Founders Fund, Gaingels, Great Oaks Venture Capital, Hitachi Ventures, sequel, Softbank Group, Streamlined Ventures.
Foundation Health has raised $26.0M across 2 funding rounds. Most recently, it raised $20.0M Series A in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $20.0M Series A | Calm/Storm Ventures, Define Ventures, Y Combinator | |
| Mar 1, 2024 | $6.0M Seed | Andreessen Horowitz, Bora&Sons, Calm/Storm Ventures, Founders Fund, Gaingels, Great Oaks Venture Capital, Hitachi Ventures, sequel, Softbank Group, Streamlined Ventures, SV Angel, Trajectory Ventures, UpHonest Capital, Walden Catalyst Ventures, Y Combinator, Jeff Bezos, Paul Graham, Richard Branson, Sam Altman |